A Decade of Cancer Data from a Tertiary Referral Center in Kenya (2015–2024): Analysis of Cancer Types and Pathology Reporting Completeness - Top-Institutions - MDSpire

A Decade of Cancer Data from a Tertiary Referral Center in Kenya (2015–2024): Analysis of Cancer Types and Pathology Reporting Completeness

  • By

  • Brian O. Ayara

  • Samuel G. Mukono

  • Rodney D. Adam

  • Shahin Sayed

  • March 9, 2026

  • 0 min

Share

Top Institutions in Pathology

Brief introduction explaining scope and methodology.

  • #1

    Aga Khan University Hospital
    Aga Khan University Hospital

    Nairobi, Kenya

    Key Differentiators

    • Oncology
    • Pathology
    • Cancer Epidemiology

  • #2

    Kenya Medical Research Institute (KEMRI)
    Kenya Medical Research Institute (KEMRI)

    Nairobi, Kenya

    Key Differentiators

    • Cancer Epidemiology
    • Public Health Research
    • Oncology

  • #3

    International Agency for Research on Cancer (IARC), WHO
    International Agency for Research on Cancer (IARC), WHO

    Lyon, France

    Key Differentiators

    • Cancer Epidemiology
    • Global Cancer Surveillance
    • Cancer Registry Development

  • #4

    Moi Teaching and Referral Hospital
    Moi Teaching and Referral Hospital

    Eldoret, Kenya

    Key Differentiators

    • Oncology
    • Pathology
    • Cancer Registry

  • #5

    University of Nairobi, School of Medicine
    University of Nairobi, School of Medicine

    Nairobi, Kenya

    Key Differentiators

    • Oncology
    • Pathology
    • Cancer Research

Original Source(s)

A Decade of Cancer Data from a Tertiary Referral Center in Kenya (2015–2024): Analysis of Cancer Types and Pathology Reporting Completeness

  • by Brian O. Ayara, Samuel G. Mukono, Rodney D. Adam, Shahin Sayed

  • March 9, 2026

Related Content

AI in Oncology: Opportunity and Accountability

Editor-in-Chief Beth Faiman discusses how advanced practitioners can use AI tools for scholarly communications, clinical documentation, and research.

Endogenous retroviruses and response to immune checkpoint inhibitors: mechanisms, clinical evidence, and therapeutic implications

Spatial organization of the tumor immune microenvironment in LAR+ triple-negative breast cancer